“Molecular Docking Studies of Schiff Bases with Azetidinone Against Dihydrofolate Reductase Enzyme as Potential Anti-cancer Agents” (2024) Asian Journal of Pharmaceutics (AJP), 18(02). doi:10.22377/ajp.v18i02.5480.